Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06601491
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-08-08
Brief Title:
Early Vascular Ageing Among Cypriots
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Lifestyle Randomised Intervention for Healthy Vascular Ageing - a Multifactorial Assessment of Vascular Ageing Among Cypriots in Early Adulthood Through Biobankcy
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LifeEVA
Brief Summary:
The LifeEVA project aims to tackle the significant public health challenge of cardiovascular disease CVD by addressing early vascular ageing EVA characterized by increased arterial stiffness and reduced vascular compliance particularly in young adults The project seeks to develop and implement innovative personalized lifestyle interventions targeting Cypriots aged 18-40 who are overweight or obese Utilizing genetic data from biobankcy LifeEVA aims to understand the progression of EVA and reduce CVD risk through tailored dietary and physical activity counseling
The methodology involves a prospective randomized open-label blinded endpoint trial over one year Participants will be recruited from biobankcys database ensuring a robust sample They will receive personalized interventions based on their genetic profile including a hypocaloric diet physical activity plan and taking into account other factors ie sleep anxiety etc The projects work is divided into five work packages project management dissemination and exploitation activities baseline assessment and recruitment intervention implementation and data collection and data analysis and manuscript preparation
Anticipated results include significant reductions in vascular stiffness improved cardiovascular health markers and enhanced understanding of the interplay between genetics and lifestyle in EVA The projects impact extends to the establishment of a vascular health assessment clinic contributions to public health by reducing CVD prevalence and advancing the field of personalized preventive healthcare LifeEVA is positioned to make significant contributions to cardiovascular research promote innovation and enhance the scientific and public health landscape in Cyprus
The methodology involves a prospective randomized open-label blinded endpoint trial over one year Participants will be recruited from biobankcys database ensuring a robust sample They will receive personalized interventions based on their genetic profile including a hypocaloric diet physical activity plan and taking into account other factors ie sleep anxiety etc The projects work is divided into five work packages project management dissemination and exploitation activities baseline assessment and recruitment intervention implementation and data collection and data analysis and manuscript preparation
Anticipated results include significant reductions in vascular stiffness improved cardiovascular health markers and enhanced understanding of the interplay between genetics and lifestyle in EVA The projects impact extends to the establishment of a vascular health assessment clinic contributions to public health by reducing CVD prevalence and advancing the field of personalized preventive healthcare LifeEVA is positioned to make significant contributions to cardiovascular research promote innovation and enhance the scientific and public health landscape in Cyprus
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None